Press Releases April 27, 2026 07:00 AM

Aeluma Appoints Willy Rachmady Vice President of Strategic Partnerships and Ecosystem

Aeluma strengthens executive leadership with appointment of semiconductor veteran Willy Rachmady as VP of Strategic Partnerships

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
ALMU

Aeluma, a NASDAQ-listed semiconductor company, has appointed Dr. Willy Rachmady as Vice President of Strategic Partnerships and Ecosystem. With over 20 years at Intel and extensive expertise in advanced semiconductor technologies, Dr. Rachmady will focus on building strategic manufacturing partnerships and accelerating commercialization of Aeluma's cutting-edge compound semiconductor products across multiple high-growth sectors.

Aeluma Appoints Willy Rachmady Vice President of Strategic Partnerships and Ecosystem
ALMU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Appointment of Dr. Willy Rachmady brings seasoned semiconductor leadership and extensive patent portfolio to helm strategic partnerships.
  • Focus on expanding ecosystem partnerships including frontend/backend fabrication, wafer-scale integration, and packaging to drive volume manufacturing.
  • Target markets include mobile, AI, defense, aerospace, robotics, automotive, AR/VR, and quantum computing technologies, broadening Aeluma's commercial footprint.

GOLETA, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, announced today it has appointed Willy Rachmady, Ph.D. as its Vice President of Strategic Partnerships and Ecosystem. In this role, Dr. Rachmady will lead foundry and ecosystem partnerships, customer engineering, and the company’s technology commercialization strategy spanning silicon photonics and compound semiconductor platforms.

Dr. Rachmady brings more than 20 years of technical and strategic leadership in advanced semiconductor technologies to Aeluma. Most recently, he served as a senior technical leader at Intel Corporation driving corporate-wide initiatives that shaped Intel’s technology and product roadmaps, strategic investments, and ecosystem partnerships. During his tenure at Intel, he made foundational contributions across advanced CMOS process development, 3D wafer stacking, heterogeneous integration, and compound semiconductor device technologies including III-V and germanium platforms. He is a named inventor on more than 350 U.S. patents and is a three-time recipient of Intel’s Top Inventor Award.

At Aeluma, Dr. Rachmady will focus on building and scaling the company’s strategic partnerships across the manufacturing ecosystem, including frontend and backend fabrication, wafer-scale integration, and packaging, while driving commercial opportunities for Aeluma’s III-V-based image sensor, high-speed photodiode, and quantum dot laser products. He will also lead the expansion of Aeluma’s intellectual property portfolio and support its technology roadmap across near- and long-term commercial horizons, including silicon photonics, co-packaged optics, and CMOS integration.

“We are thrilled to welcome Willy to the Aeluma team,” said Jonathan Klamkin, Ph.D., President and CEO. “His rare combination of deep process technology expertise, broad ecosystem relationships, and strategic perspective is exactly what we need at this stage of the company’s growth. With commercial interest building across our target markets, Willy’s appointment strengthens our ability to execute on our commercial roadmap and accelerate our path to volume manufacturing.”

Dr. Rachmady added, “Aeluma has built an impressive technology foundation with a product portfolio uniquely positioned at the intersection of compound semiconductors and scalable manufacturing. I’m excited to help translate that foundation into strategic partnerships and market wins that define Aeluma’s next phase of growth.”

Dr. Rachmady holds a Ph.D. in Chemical Engineering from Pennsylvania State University and will report directly to President and CEO Dr. Jonathan Klamkin.

About Aeluma

Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.

Company:
Aeluma, Inc.
(805) 351-2707
[email protected]

Investor Contact:
Financial Profiles, Inc.
Alex Villalta
(310) 622-8227
[email protected]


Risks

  • Execution risk in scaling strategic partnerships and volume manufacturing capabilities requisite for commercial success.
  • Market competition in advanced semiconductor and photonics sectors could impact commercial adoption of Aeluma's technology.
  • Technology commercialization timelines and ability to meet roadmap targets may influence investor confidence and revenue realization.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026